Company intelligence / Profile preview

RxLongevity

Ownership: Private
Development stage: Commercial

Overview

RxLongevity offers a digital longevity coaching service aimed at seniors aged 60–80. The company provides personalized plans to increase healthy lifespan through daily live sessions, group consultations, boot camps covering physical therapy, exercise, nutrition, inflammation management, brain exercises, emotional health and sexuality after age 65. The service is delivered via a mobile app with video content and an AI-powered virtual coach. There are no clinical trial results as the product is not a drug or device but a digital health solution.

Therapeutic areas: OtherNeurology
Modalities: Non-pharmacological therapyDigital therapeuticMobile app-based intervention
Industry: Non-Academic Healthcare

Partnerships

Some support from EIT Health Innovators Community

Beyond the preview

Go deeper on RxLongevity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxLongevity.

Explore the full profile